On testosterone and Low T

On testosterone and Low T

From Drug Story by Thomas Goetz

February 10, 2026 · 57 min · Season 1 · Episode 6

About this episode

This episode explores the mainstream acceptance of testosterone therapy and its implications on aging and men's health.

It used to be that getting older meant slowing down. A little less pep, a little less zip, a little less zest. So it goes. For men, this was partly about testosterone. After 40 or so, our bodies produce less and less testosterone, the hormone that helps give men energy and vigor and sex drive. Lower testosterone was just part of growing older. But that was then! Nowadays, “Low T” is a bonafide medical condition - easily treated with a shot at your local neighborhood men’s health clinic. Today, what used to be a secret sauce of bodybuilders or cheating athletes is now downright normal. Millions of men worldwide take testosterone therapy - and not just those over 40. Check out Reddit or TikTok...It is a WHOLE THING . In this episode of Drug Story, we look at how TRT went mainstream, and how part of ordinary aging somehow became a disease. Sources for this episode [1] Male Hypogonadism (2024) STAT Pearls :Male hypogonadism is defined as inadequate testosterone production or impaired spermatogenesis, diagnosed via symptoms and low morning testosterone levels. [2] Brown-Séquard: An improbable genius who transformed medicine (2011) The Journal of Clinical Investigation…

People in this episode

Host: Thomas Goetz

Topics covered

  • testosterone
  • Low T
  • men's health
  • aging
  • hormone therapy
  • TRT
  • medical condition

Keywords

  • testosterone
  • Low T
  • TRT
  • men's health
  • aging
  • hormone therapy
  • medical condition

Mentioned in this episode

Organizations: Reddit, TikTok

Books & works: Male Hypogonadism, Brown-Séquard: An improbable genius who transformed medicine, The life and legacy of Brown-Séquard

More episodes of Drug Story

Explore listener stats, chart rankings, contacts and more on the Drug Story podcast page.